Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
American Heart Association
https://newsroom.heart.org/news/new-anti-clotting-medication-reduces-bleeding-among-people-with-atrial-fibrillation